Inotiv, Inc. (NOTVQ)

OTCMKTS · Delayed Price · Currency is USD

0.0360

-0.0091 (-20.18%)

At close: Jun 15, 2026

-98.38% (1Y)

Market Cap	1.26M -98.7%
Revenue (ttm)	507.36M +5.6%
Net Income	-86.97M
EPS	-2.53
Shares Out	34.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,698,136
Open	0.0406
Previous Close	0.0451
Day's Range	0.0250 - 0.0451
52-Week Range	0.0250 - 2.4400
Beta	3.77
Analysts	Strong Buy
Price Target	5.00 (+13,788.89%)
Earnings Date	n/a

About Inotiv

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the ... [Read more]

Industry Commercial Physical and Biological Research

Founded 1974

Employees 2,046

Stock Exchange OTCMKTS

Ticker Symbol NOTVQ

Full Company Profile

Financial Performance

In fiscal year 2025, Inotiv's revenue was $513.02 million, an increase of 4.54% compared to the previous year's $490.74 million. Losses were -$68.63 million, -36.72% less than in 2024.

Financial Statements